Clinical practice guideline for the eradicating therapy of Helicobacter pylori infections associated to duodenal ulcer in primary care
Jovell A J, Aymerich M, Garcia-Altes A, Serra-Prat M
Record ID 31999008076
Catalan, English, Spanish
Authors' objectives:
1. To assess the efficacy and safety of the eradication therapy of Helicobacter pylori.
2. To assess the efficiency of the eradication therapy of infection by Helicobacter pylori administered empirically.
3. To design a clinical practice guideline ofthe eradication therapy of infection by Helicobacter pylori associated to gastro-duodenal ulcers in primary care.
Authors' recommendations:
The results of the meta-analysis of randomised controlled trials showed higher efficacy of the triple therapy in the eradication of Helicobacter pylori and in newly diagnosed gastric or duodenal ulcershealing.
The results of the clinical decision analysis model show the best cost-effectiveness ratio for the empirical administration without diagnostic confirmation of triple therapy in the cases of newly diagnosed, non-complicated duodenal ulcer.
The selection of the antibiotics of choice should consider the local and national profile of bacterial resistances, since it may change the therapy's effectiveness.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
1998
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Spain
MeSH Terms
- Costs and Cost Analysis
- Duodenal Ulcer
- Helicobacter pylori
- Peptic Ulcer
- Helicobacter Infections
Contact
Organisation Name:
Agencia de Qualitat i Avaluacio Sanitries de Catalunya
Contact Address:
Antoni Parada, CAHTA, Roc Boronat, 81-95 (2nd floor), 08005 Barcelona, Spain, Tel. +34 935 513 928, Fax: +34 935 517 510
Contact Name:
direccio@aatrm.catsalut.net / aparada@aatrm.catsalut.net
Contact Email:
direccio@aatrm.catsalut.net / aparada@aatrm.catsalut.net
Copyright:
Catalan Agency for Health Technology Assessment and Research
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.